General Information of DTT (ID: TTTSGRH)

DTT Name Leucine-rich repeat-containing GPCR 5 (LGR5) DTT Info
Gene Name LGR5

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Preclinical Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BNC-101 DMSBM6A Metastatic colorectal cancer 2B91 Phase 1 [1]
MCLA-158 DMF0O3X Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
------------------------------------------------------------------------------------
1 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BNC-102 DMM1O0P Solid tumour/cancer 2A00-2F9Z Preclinical [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
KM-4056 DMK17GN Solid tumour/cancer 2A00-2F9Z Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Bionomics.
2 Clinical pipeline report, company report or official report of Merus.
3 Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov. 2017 Sep 1;16(9):661.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 148).